Alkaloid AD Skopje (XMAE:ALK) ROCE %: 14.50% (As of Mar. 2026)

What is Alkaloid AD Skopje ROCE %?

Alkaloid AD Skopje XMAE:ALK +0.21% 88 ROCE % is 14.50% as of Mar. 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 88/100 and a GF Value™ of MKD27,166.15 (Modestly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alkaloid AD Skopje's annualized ROCE % for the quarter that ended in Mar. 2026 was 14.50%.

Alkaloid AD Skopje (XMAE:ALK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alkaloid AD Skopje ROCE % Related Terms

Alkaloid AD Skopje ROCE % Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje ROCE % Chart

Alkaloid AD Skopje Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

12.33

13.07

13.16

13.29

13.58

Alkaloid AD Skopje Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															14.98	11.09	17.91	10.26	14.50

88GF Score

Alkaloid AD Skopje XMAE:ALK

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Alkaloid AD Skopje ROCE % Calculation

Alkaloid AD Skopje's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	2226.535	/	( ( (21471.232 - 5965.591)	+	(24354.919 - 7060.116) )	/ 2 )
	=	2226.535	/	( (15505.641	+	17294.803)	/ 2 )
	=	2226.535	/	16400.222
	=	13.58 %

Alkaloid AD Skopje's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	2506.94	/	( ( (24354.919 - 7060.116)	+	(0 - 0) )	/ 1 )
	=	2506.94	/	( ( 17294.803	+	0 )	/ 1 )
	=	2506.94	/	17294.803
	=	14.50 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 14.50% mean?

Alkaloid AD Skopje (XMAE:ALK) has a ROCE % of 14.50% as of Mar. 2026.

Is Alkaloid AD Skopje's ROCE % too high?

Alkaloid AD Skopje's current ROCE % is 14.50%. The Drug Manufacturers industry median ROCE % is 7.00. Alkaloid AD Skopje's value of 14.50% is 107.3% above this industry median. Overall, Alkaloid AD Skopje has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Alkaloid AD Skopje's ROCE % compare to ZTS and UTHR?

Alkaloid AD Skopje's ROCE % of 14.50% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Alkaloid AD Skopje's value of 14.50% is 107.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alkaloid AD Skopje's current ROCE % of 14.50% is 107.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkaloid AD Skopje's current ROCE % is 14.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Alkaloid AD Skopje stock overvalued right now?

Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,300.00 — trading 10.6% below its estimated fair value. The current ROCE % is 14.50% and 107.3% above the Drug Manufacturers industry median of 7.00. Alkaloid AD Skopje's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current ROCE % is 14.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD24,300.00 is trading 10.6% below its estimated GF Value™ of MKD27,166.15. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

ROCE %: 14.50%
GF Value™: MKD27,166.15 vs. price of MKD24,300.00 (10.6% below fair value)
GF Score™: 88/100
Industry Position: 107.3% above the Drug Manufacturers median

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkaloid AD Skopje Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692 UTHR VTRS NSE:DIVISLAB OSTO:SOBI TSE:4507 NBIX NSE:TORNTPHARM XPAR:IPN SHSE:688506 SZSE:002001

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000

Website http://www.alkaloid.com.mk

Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.

88GF Score

Get the complete analysis for XMAE:ALK

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD24,300.00

Price

MKD27,166.15

GF Value

View XMAE:ALK Analysis

See ROCE % data for all stocks →